S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
STXS · Stereotaxis, Inc.
NYSE MKT LLC - BOATS Real Time Price • USD
$0.98
-0.00
(-0.34%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$0.98
$0.98
$1.02
52-WEEK RANGE
$0.98
$0.95
$3.15
What's happening
- STXS is down 0.34% today, trading at $0.98. — Live quote
- It's trading within 3% of its 52-week low ($0.95). (Finnhub fundamentals)
- Volume today (17,768) is well below its 3-month average of 765,570. (Finnhub fundamentals)
- Reports earnings on 2026-11-10 (after market close), 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.05 actual vs. $-0.05 estimated (+2.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 6
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (9 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
STXS
-56.60%
vs S&P 500
-69.37%
1-YEAR RETURN
STXS
-67.80%
vs S&P 500
-82.36%
6-MONTH RETURN
STXS
-50.33%
3-MONTH RETURN
STXS
-32.09%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.05
Est. $-0.05
BEAT +2.0%
2026-04-26 (Q1 2026)
$-0.06
Est. $-0.05
MISS -19.5%
2026-01-26 (Q4 2025)
$-0.06
Est. $-0.07
BEAT +10.0%
2025-10-26 (Q3 2025)
$-0.07
Est. $-0.06
MISS -14.4%
Valuation Measures & Ratios
Enterprise Value4$88.7M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)3.30
Price / Book79.64
EV4 / Revenue2.95
EV4 / EBITDA192.85
Profit Margin-74.24%
Operating Margin-75.68%
Return on Equity (ROE8)-132.62%
Return on Assets (ROA9)-43.04%
Avg Volume (3M)765,570
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $154.6M | $179.7M | $289.5M | $162.2M | $146.4M |
| P/E | -7.50 | -8.18 | -12.98 | -7.49 | -6.55 |
| Price/Sales | 5.12 | 5.99 | 8.79 | 5.41 | 5.22 |
| Price/Book | 12.63 | 12.52 | 46.19 | 111.42 | 50.84 |
| EV/Revenue | 4.77 | 5.50 | 8.47 | 5.18 | 4.84 |
| ROE | -168.41% | -153.04% | -355.92% | -1488.46% | -776.15% |
| ROA | -37.09% | -40.67% | -48.92% | -52.64% | -48.91% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,681,816
Change from Prior Settlement+1.88%
% of Float—
Days to Cover (Short Ratio)11.58
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 10-Q, filed 2026-08-12; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -12.8% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -74.2%. Finnhub fundamentals ↗
- Trailing 52-week price return is -67.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on STXS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.7M | $6.3M | $7.5M | $8.8M | $7.5M | $9.2M | $4.5M | $6.9M |
| Gross profit | $4.5M | $3.8M | $4.1M | $4.6M | $4.1M | $4.1M | $3.3M | $4.0M |
| Operating income | -$4.6M | -$6.0M | -$6.6M | -$4.0M | -$5.9M | -$6.3M | -$6.0M | -$4.7M |
| Net income | -$4.5M | -$5.9M | -$6.5M | -$3.8M | -$5.8M | -$6.2M | -$5.8M | -$4.5M |
| EPS (diluted) | $-0.05 | $-0.06 | $-0.07 | $-0.05 | $-0.07 | $-0.08 | $-0.07 | $-0.06 |
| EPS (basic) | $-0.05 | $-0.06 | $-0.07 | $-0.05 | $-0.07 | $-0.08 | $-0.07 | $-0.06 |
| Operating margin | -$60 | -$95 | -$88 | -$45 | -$79 | -$69 | -$134 | -$69 |
| Net margin | -$58 | -$93 | -$87 | -$43 | -$78 | -$67 | -$130 | -$66 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $55.6M | $54.0M | $52.3M | $45.6M | $41.2M | $45.7M | $46.7M | $50.9M |
| Total liabilities | $38.1M | $34.4M | $33.5M | $34.1M | $34.4M | $37.5M | $35.3M | $34.7M |
| Stockholders' equity | $12.2M | $14.4M | $13.5M | $6.3M | $1.5M | $2.9M | $6.1M | $10.8M |
| Total current assets | $38.0M | $36.0M | $33.8M | $26.7M | $21.9M | $25.9M | $26.4M | $28.8M |
| Total current liabilities | $26.8M | $23.1M | $22.4M | $20.4M | $20.7M | $24.2M | $21.6M | $20.7M |
| Cash & equivalents | $10.5M | $14.6M | $13.4M | $10.5M | $7.0M | $10.6M | $12.2M | $10.7M |
| Marketable securities (current) | $0 | — | $0 | $0 | — | — | $0 | — |
| Accounts receivable | $7.5M | $5.3M | $5.8M | $5.3M | $4.4M | $4.3M | $3.8M | $7.9M |
| Inventory | $12.5M | $10.5M | $9.6M | $10.1M | $9.6M | $9.8M | $8.3M | $9.0M |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $2.9M | $3.0M | $3.0M | $3.2M | $3.3M | $3.4M | $3.6M | $3.7M |
| Goodwill | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $4.5M |
| Intangible assets | $6.0M | $6.2M | $6.4M | $6.7M | $6.9M | $7.1M | $7.4M | $8.2M |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $6.9M | $4.8M | $4.8M | $4.7M | $6.7M | $6.5M | $5.7M | $6.4M |
| Accrued liabilities | $1.3M | $1.5M | $2.1M | $2.0M | $1.7M | $2.9M | $2.9M | $3.4M |
| Deferred revenue (current) | $5.9M | $6.5M | $5.7M | $7.5M | $5.8M | $8.2M | $6.8M | $5.1M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $64.0K | $64.0K | $55.0K |
| Common stock & paid-in capital | $98.0K | $97.0K | $95.0K | $91.0K | $86.0K | $86.0K | $85.0K | $85.0K |
| Retained earnings | -$593.7M | -$589.2M | -$583.4M | -$577.8M | -$571.4M | -$567.5M | -$561.7M | -$554.2M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.7M | -$3.4M | -$4.0M | -$4.2M | -$3.7M | -$1.8M | $1.3M | -$4.3M |
| Investing cash flow | -$1.1M | -$79.0K | -$70.0K | $0 | -$23.0K | — | -$2.0K | $98.0K |
| Financing cash flow | $695.0K | $4.7M | $7.0M | $7.7M | $34.0K | $32.0K | $159.0K | $80.0K |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $1.6M | $2.1M | $2.4M | $2.5M | $2.4M | $2.5M | $2.6M | $2.6M |
| Deferred income taxes | — | — | $2.2M | — | — | — | $2.2M | — |
| Change in accounts receivable | $1.2M | -$543.0K | $514.0K | $940.0K | $69.0K | $500.0K | -$4.1M | $4.4M |
| Change in inventory | $2.0M | $928.0K | -$580.0K | $539.0K | -$204.0K | $1.5M | -$58.0K | -$1.5M |
| Change in accounts payable | $2.1M | -$49.0K | $135.0K | -$2.1M | $210.0K | $852.0K | -$690.0K | $502.0K |
| Dividends paid | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $32.4M | $26.9M | $26.8M | $28.1M | $35.0M |
| Gross profit | $17.1M | $14.6M | $14.9M | $18.5M | $23.2M |
| Operating income | -$22.1M | -$24.7M | -$21.8M | -$18.8M | -$12.9M |
| Net income | -$21.6M | -$24.0M | -$20.7M | -$18.3M | -$10.7M |
| EPS (diluted) | $-0.25 | $-0.30 | $-0.27 | $-0.26 | $-0.16 |
| EPS (basic) | $-0.25 | $-0.30 | $-0.27 | $-0.26 | $-0.16 |
| Operating margin | -$68 | -$92 | -$82 | -$67 | -$37 |
| Net margin | -$67 | -$89 | -$77 | -$65 | -$31 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $52.3M | $46.7M | $41.9M | $53.4M | $61.0M |
| Total liabilities | $33.5M | $35.3M | $20.0M | $21.5M | $21.6M |
| Stockholders' equity | $13.5M | $6.1M | $16.3M | $26.3M | $33.8M |
| Total current assets | $33.8M | $26.4M | $33.3M | $43.2M | $51.4M |
| Total current liabilities | $22.4M | $21.6M | $13.2M | $14.3M | $13.3M |
| Cash & equivalents | $13.4M | $12.2M | $19.8M | $8.6M | $38.7M |
| Marketable securities (current) | — | — | — | $19.8M | — |
| Accounts receivable | $5.8M | $3.8M | $3.8M | $5.1M | $5.4M |
| Inventory | $9.6M | $8.3M | $8.4M | $7.9M | $4.4M |
| Other current assets | — | — | — | — | — |
| Property, plant & equipment | $3.0M | $3.6M | $3.3M | $3.8M | $2.6M |
| Goodwill | $3.8M | $3.8M | — | — | — |
| Intangible assets | $6.4M | $7.4M | — | — | — |
| Other non-current assets | — | — | — | — | $278.2K |
| Accounts payable | $4.8M | $5.7M | $3.2M | $3.3M | $4.2M |
| Accrued liabilities | $2.1M | $2.9M | $3.0M | $3.3M | $2.5M |
| Deferred revenue (current) | $5.7M | $6.8M | $6.7M | $7.3M | $6.3M |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $1.1M | $64.0K | $43.0K | $51.0K | $218.0K |
| Common stock & paid-in capital | $95.0K | $85.0K | $81.0K | $75.0K | $75.0K |
| Retained earnings | -$583.4M | -$561.7M | -$537.7M | -$517.0M | -$498.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$13.7M | -$8.5M | -$9.1M | -$8.4M | -$2.9M |
| Investing cash flow | -$93.0K | $74.0K | $19.8M | -$22.1M | -$1.4M |
| Financing cash flow | $14.8M | $297.0K | $81.0K | $220.0K | $547.0K |
| Share-based compensation | $9.9M | $10.3M | $10.6M | $10.6M | $9.4M |
| Deferred income taxes | $2.2M | $2.2M | $2.9M | $2.1M | $1.7M |
| Change in accounts receivable | $2.0M | -$691.0K | -$1.3M | -$316.0K | $1.9M |
| Change in inventory | $1.2M | -$677.0K | $550.0K | $2.9M | $1.1M |
| Change in accounts payable | -$880.0K | $758.0K | $218.0K | -$169.0K | $1.4M |
| Dividends paid | — | — | — | — | — |
| Debt repaid | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding STXS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-01-02 to 2026-07-01
Recent transactions
- Most recent: SHAMIR NACHUM (Director) — Grant / award of 43,103 shares on 2026-07-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| SHAMIR NACHUM | Director | Grant / award | 2026-07-01 | 43,103 |
| Benfer David | Director | Grant / award | 2026-07-01 | 43,103 |
| Levin Ross B | Director | Grant / award | 2026-07-01 | 43,103 |
| Curet Myriam | Director | Grant / award | 2026-07-01 | 43,103 |
| Fischel Nathan | Director | Grant / award | 2026-07-01 | 43,103 |
| Menawat Arun Swarup | Director | Grant / award | 2026-07-01 | 43,103 |
| Isaac Paul J | Director | Open market purchase | 2025-11-17 | 10,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-01 | SHAMIR NACHUM | Director | Grant / award | 43,103 | $0.00 |
| 2026-07-01 | Benfer David | Director | Grant / award | 43,103 | $0.00 |
| 2026-07-01 | Levin Ross B | Director | Grant / award | 43,103 | $0.00 |
| 2026-07-01 | Curet Myriam | Director | Grant / award | 43,103 | $0.00 |
| 2026-07-01 | Fischel Nathan | Director | Grant / award | 43,103 | $0.00 |
| 2026-07-01 | Menawat Arun Swarup | Director | Grant / award | 43,103 | $0.00 |
| 2026-01-02 | Menawat Arun Swarup | Director | Grant / award | 46,948 | $0.00 |
| 2026-01-02 | Benfer David | Director | Grant / award | 46,948 | $0.00 |
| 2026-01-02 | Curet Myriam | Director | Grant / award | 46,948 | $0.00 |
| 2026-01-02 | Fischel Nathan | Director | Grant / award | 46,948 | $0.00 |
| 2026-01-02 | Levin Ross B | Director | Grant / award | 46,948 | $0.00 |
| 2026-01-02 | SHAMIR NACHUM | Director | Grant / award | 46,948 | $0.00 |
| 2025-11-17 | Isaac Paul J | Director | Open market purchase | 10,000 | $2.18 |
| 2025-11-14 | Isaac Paul J | Director | Open market purchase | 20,000 | $2.24 |
| 2025-07-01 | Fischel Nathan | Director | Grant / award | 43,668 | $0.00 |
| 2025-07-01 | Levin Ross B | Director | Grant / award | 43,668 | $0.00 |
| 2025-07-01 | Benfer David | Director | Grant / award | 43,668 | $0.00 |
| 2025-07-01 | Curet Myriam | Director | Grant / award | 43,668 | $0.00 |
| 2025-07-01 | Menawat Arun Swarup | Director | Grant / award | 43,668 | $0.00 |
| 2025-07-01 | SHAMIR NACHUM | Director | Grant / award | 43,668 | $0.00 |
| 2025-03-10 | Isaac Paul J | Director | Open market purchase | 38,000 | $1.81 |
| 2025-03-07 | Isaac Paul J | Director | Open market purchase | 1,489 | $1.79 |
| 2025-03-06 | Isaac Paul J | Director | Open market purchase | 23,299 | $1.81 |
| 2025-01-02 | Levin Ross B | Director | Grant / award | 56,497 | $0.00 |
| 2025-01-02 | Menawat Arun Swarup | Director | Grant / award | 56,497 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:24 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-12 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-11 | 8-K | 2026-08-11 | View on SEC.gov → |
| 2026-07-16 | 8-K | 2026-07-15 | View on SEC.gov → |
| 2026-07-09 | 8-K | 2026-07-07 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-05-15 | 8-K | 2026-05-14 | View on SEC.gov → |
| 2026-05-13 | 10-Q | 2026-03-31 | View on SEC.gov → |
Recent news
Headlines about STXS (Stereotaxis, Inc.). Links open the publisher — we don’t host full articles.
-
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
Yahoo · 2026-10-20 -
Global Electrophysiology Devices Market Size, Share, Growth, and Forecast 2026-2035 | Pulsed Field Ablation and 3D Mapping Fuel 12.40% CAGR to USD 30.16 Billion by 2035
Yahoo · 2026-10-15 -
ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters
Yahoo · 2026-10-13 -
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
Yahoo Finance · 2026-09-16 -
Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition?
Yahoo Finance · 2026-09-14 -
Stereotaxis: A Real Product Story, But The Stock Already Prices In Success
Seeking Alpha · 2026-09-05 -
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
Yahoo Finance · 2026-09-03 -
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-18
No headlines in this category right now — try “All”.